Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Deodhar

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
G3 (Bethesda, Md.)|November 25, 2015
An RNAi-Based Candidate Screen for Modifiers of the CHD1 Chromatin Remodeler and Assembly Factor in Drosophila melanogasterSharon Kim, Lakshmi Bugga, Eugenie S Hong, et al.
JAMA Dermatology|June 21, 2013
Implications for biologic therapy: Staphylococcus aureus decolonization of individuals with a history of recurrent skin and soft-tissue infectionsJennifer H Ku, Kevin L Winthrop, Cara D Varley, et al.
BMC Rheumatology|March 12, 2020
Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world studyA Deodhar, V Strand, P G Conaghan, et al.
Rheumatology (Oxford, England)|November 1, 2013
Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapyCara D Varley, Atul A Deodhar, Benjamin D Ehst, et al.
Clinical Rheumatology|February 6, 2019
Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world studyRieke Alten, P G Conaghan, V Strand, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trialXenofon Baraliakos, Alan J Kivitz, Atul A Deodhar, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 2, 2022
Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE StudyAtul A Deodhar, Natalie J Shiff, Cinty Gong, et al.
Clinical Rheumatology|July 28, 2021
Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world studyT Korotaeva, O Dina, E Holdsworth, et al.
Clinical, Cosmetic and Investigational Dermatology|December 2, 2015
Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritisB Truong, N Rich-Garg, B D Ehst, et al.
Clinical Rheumatology|January 27, 2022
Correction to: Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real‑world studyT Korotaeva, O Dina, E Holdsworth, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
G3 (Bethesda, Md.)|November 25, 2015
An RNAi-Based Candidate Screen for Modifiers of the CHD1 Chromatin Remodeler and Assembly Factor in Drosophila melanogasterSharon Kim, Lakshmi Bugga, Eugenie S Hong, et al.
JAMA Dermatology|June 21, 2013
Implications for biologic therapy: Staphylococcus aureus decolonization of individuals with a history of recurrent skin and soft-tissue infectionsJennifer H Ku, Kevin L Winthrop, Cara D Varley, et al.
BMC Rheumatology|March 12, 2020
Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world studyA Deodhar, V Strand, P G Conaghan, et al.
Rheumatology (Oxford, England)|November 1, 2013
Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapyCara D Varley, Atul A Deodhar, Benjamin D Ehst, et al.
Clinical Rheumatology|February 6, 2019
Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world studyRieke Alten, P G Conaghan, V Strand, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trialXenofon Baraliakos, Alan J Kivitz, Atul A Deodhar, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 2, 2022
Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE StudyAtul A Deodhar, Natalie J Shiff, Cinty Gong, et al.
Clinical Rheumatology|July 28, 2021
Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world studyT Korotaeva, O Dina, E Holdsworth, et al.
Clinical, Cosmetic and Investigational Dermatology|December 2, 2015
Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritisB Truong, N Rich-Garg, B D Ehst, et al.
Clinical Rheumatology|January 27, 2022
Correction to: Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real‑world studyT Korotaeva, O Dina, E Holdsworth, et al.
Pageof 10